(PDF) Levels of CD56+TIM-3- Effector CD8 T Cells

Levels of CD56+TIM-3- Effector CD8 T Cells Distinguish HIV Natural Virus Suppressors From Patients Receiving Antiretroviral Therapy

PLoS ONE - United States

doi 10.1371/journal.pone.0088884

Full Text

Abstract

Available in full text

Categories

Multidisciplinary

Date

February 10, 2014

Authors

Publisher

Public Library of Science (PLoS)

Related search

Effect of IL-7 Therapy on Phospho-Ribosomal Protein S6 and TRAF1 Expression in HIV-Specific CD8 T Cells in Patients Receiving Antiretroviral Therapy

Journal of Immunology

English

TIM-3 Engagement Promotes Effector Memory T Cell Differentiation of Human Antigen-Specific CD8 T Cells by Activating mTORC1

Journal of Immunology

English

A Subset of CD4/CD8 Double-Negative T Cells Expresses HIV Proteins in Patients on Antiretroviral Therapy

Journal of Virology

English

Prolonged Antiretroviral Therapy Preserves HIV-1-Specific CD8 T Cells With Stem Cell-Like Properties

Journal of Virology

English

CD8+ T Cells From HLA-B*57 Elite Suppressors Effectively Suppress Replication of HIV-1 Escape Mutants

Infectious Diseases

English

Presence of Suppressor HIV-Specific CD8+ T Cells Is Associated With Increased PD-1 Expression on Effector CD8+ T Cells

Journal of Immunology

English

Clinical Relevance of Drug Interactions in HIV-Infected Patients Receiving Antiretroviral Therapy

English

Immunologic Activity and Safety of Autologous HIV RNA-electroporated Dendritic Cells in HIV-1 Infected Patients Receiving Antiretroviral Therapy

Clinical Immunology

English

Quantification of HIV-1 Latency Reversal in Resting CD4+ T Cells From Patients on Suppressive Antiretroviral Therapy

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English